Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Autoimmune
Santa Ana Bio launches with $168M in funding, precision approach
By
LabPulse.com staff writers
Precision biotech firm Santa Ana Bio announced its launch with $168 million in combined series A and B funding.
June 14, 2024
Biogen bets $1.15B on HI-Bio's autoimmune kidney disease drug
By
LabPulse.com staff writers
The therapy could ultimately improve clinical outcomes in a broad range of immune-mediated diseases, according to Biogen.
May 22, 2024
AbbVie to buy Landos Biopharma for up to $212M
By
LabPulse.com staff writers
AbbVie has announced that it will buy drug developer Landos Biopharma in a deal worth up to $212 million. The deal will expand Abbvie’s portfolio, especially in the arena of immune system-related illnesses.
March 25, 2024
‘Remarkable’ results in lupus patients spark speculation CAR-T may cure autoimmunity
By
Nick Paul Taylor
The generation of “remarkable” results in lupus patients has sparked speculation about the potential for chimeric antigen receptor T-cell (CAR-T cell) therapy to cure autoimmune diseases.
February 23, 2024
Scipher Medicine, Quest Diagnostics collaborate on RA diagnostics
By
LabPulse.com staff writers
Scipher Medicine and Quest Diagnostics have announced a multiyear collaboration to expand access to diagnostic services for patients with rheumatoid arthritis (RA).
November 28, 2023
Rome Therapeutics raises $72M in series B financing
By
Matt Limb
Biotech company Rome Therapeutics has raised a further $72 million in financing to develop medicines for autoimmune diseases and continue its exploration of the “dark genome.”
September 20, 2023
Twist Bioscience, Ono Pharmaceutical to collaborate on autoimmune disease drug development
By
LabPulse.com staff writers
Synthetic biology and genomics company Twist Bioscience has entered into a collaboration with Ono Pharmaceutical, one of the largest pharmaceutical companies in Japan, to discover and develop drugs for autoimmune diseases.
September 5, 2023
Microbiome analysis reveals signatures of arthritic conditions in human gut
By
Nick Paul Taylor
The analysis revealed changes to the microbiome in people with inflammatory arthritis conditions. Oral, proinflammatory, and mucin-degrading microbes were enriched in these patients at the expense of some organisms typically found in the human gut.
August 4, 2023
Screening newborns for severe combined immunodeficiency saves lives, study finds
By
Elissa Wolfson
In a study, widespread screening and early treatment of newborn babies with severe combined immunodeficiency boosted their five-year survival rate from 73% to 87%.
June 21, 2023
COVID-19’s 'long tail' analyzed at European rheumatology congress
By
Elissa Wolfson
EULAR’s 2023 Congress includes presentations on iRD patients’ susceptibility to long COVID, and COVID-19 vaccination safety in pregnant and breastfeeding women with autoimmune disease.
May 31, 2023
Werfen completes $2B acquisition of Immucor, expands presence in specialized diagnostics
By
LabPulse.com staff writers
Immucor's transfusion and transplant product lines complement Werfen's hemostasis, acute care, and autoimmunity business lines, and expand the parent firm's portfolio of specialized diagnostic products for hospitals and clinical laboratories.
March 15, 2023
Prometheus Biosciences announces $500M stock offering
By
LabPulse.com staff writers
The San Diego-based biotech company is taking a precision medicine approach for the discovery, development, and commercialization of therapeutic and companion diagnostic products for the treatment of immune-mediated diseases.
December 12, 2022
Page 1 of 9
Next Page
